APA (7th ed.) Citation

Milani, M., Donalisio, M., Bonotto, R. M., Schneider, E., Arduino, I., Boni, F., . . . Mastrangelo, E. (2021). Combined in silico and in vitro approaches identified the antipsychotic drug lurasidone and the antiviral drug elbasvir as SARS-CoV2 and HCoV-OC43 inhibitors. Antiviral Research, 189, N.PAG. https://doi.org/10.1016/j.antiviral.2021.105055

Chicago Style (17th ed.) Citation

Milani, Mario, Manuela Donalisio, Rafaela Milan Bonotto, Edoardo Schneider, Irene Arduino, Francesco Boni, David Lembo, Alessandro Marcello, and Eloise Mastrangelo. "Combined in Silico and in Vitro Approaches Identified the Antipsychotic Drug Lurasidone and the Antiviral Drug Elbasvir as SARS-CoV2 and HCoV-OC43 Inhibitors." Antiviral Research 189 (2021): N.PAG. https://doi.org/10.1016/j.antiviral.2021.105055.

MLA (9th ed.) Citation

Milani, Mario, et al. "Combined in Silico and in Vitro Approaches Identified the Antipsychotic Drug Lurasidone and the Antiviral Drug Elbasvir as SARS-CoV2 and HCoV-OC43 Inhibitors." Antiviral Research, vol. 189, 2021, p. N.PAG, https://doi.org/10.1016/j.antiviral.2021.105055.